Latest news
Loading news…
GeneTx Biotherapeutics
ClosedOperating status — whether the company still runs independently. “Closed” usually means it was acquired, merged, or shut down.🔥 MediumHeat score — how much recent activity & attention the company has (web traffic, news, hiring). Downers Grove, Illinois, United States Founded 2017 1001-5000 employees For Profit
GeneTx Biotherapeutics is a biotechnology company that focuses on developing therapeutics for the treatment of Angelman syndrome.
GeneTx Biotherapeutics was acquired by Ultragenyx Pharmaceutical in 2022 for $75M.
Total Funding
Available in Pro Last Funding
Available in Pro Acquisitions
0
Monthly Visits
Available in Pro Contacts
2
Company Details
Funding & Financials
Pro- Total funding
- Funding rounds
- Last funding
- Last funding type
- Last funding date
- Funding status
- Total equity funding
- Revenue range
IPO & Stock
- IPO status
- Private
Web Traffic
Pro- Monthly visits
- Global traffic rank
- 6-mo avg visits
- Visit duration (s)
- Pages / visit
- Bounce rate
- Rank change (mo)
Technology & IP
- Active technologies
- 7
- IT spend
- $60.16K
Company Info
- Founded
- 2017
- Employees
- 1001-5000
- Operating status
- Closed
- Company type
- For Profit
- Org types
- company
- Founders
- 2
- News articles
- 13
- HQ
- Downers Grove, Illinois, United States
- Region
- Greater Chicago Area, Great Lakes, Midwestern US
- Diversity spotlight
- Women Founded; Women Led
- Exit date
- Jul 18, 2022
Signals & Scores
- Heat score
- Medium
- Trend (7d)
- -0.3
- Trend (30d)
- -1.8
- Trend (90d)
- 2.9
- Last layoff mention
- Nov 14, 2025
Key People at GeneTx Biotherapeutics
CEO & Co-Founder
2
professional contacts at GeneTx Biotherapeutics
Contact execs at GeneTx Biotherapeutics →Explore 200,000+ acquisitions — free
Filter the full database across sectors, companies, dates, and deal sizes. No signup, no paywall.
Recent News related to GeneTx Biotherapeutics
Loading news…
FAQs about GeneTx Biotherapeutics
People who checked this page also checked these
Browse the full Acquirezy directory.